News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. equities are outperforming China due to concentrated AI infrastructure investment.
  • U.S. industrial production is improving, supporting the market's momentum.
  • China's markets remain subdued because of a prolonged property downturn.
  • Potential U.S.-Iran sanctions relief could channel economic gains to the IRGC, raising compliance risk for international firms.
  • Porsche seeks to finalize a second round of employee cost cuts before July factory holidays amid profit pressure.
  • Analysts pitch Tantalus Systems as a discounted smart-grid growth stock after steady contract wins and rising software revenue potential.

Latest Articles

Cuprina Shares Jump After FDA Clears MEDIFLY Maggots for Wound Debridement

Cuprina Shares Jump After FDA Clears MEDIFLY Maggots for Wound Debridement

Shares of Cuprina Holdings surged 50% after the company disclosed that a subsidiary received FDA 510(k) clearance for MEDIFLY Maggots, a prescription, medical-grade Lucilia cuprina larvae product intended for maggot debridement therapy in non-healing necrotic skin and soft tissue wounds. The clearance grants U.S. commercial rights for this species …

Raymond James Analyst Sees Short-Term Equity Rally Building Into July

Raymond James Analyst Sees Short-Term Equity Rally Building Into July

A Raymond James technical analyst says a fresh, short-term rally in North American equities has begun, driven primarily by easing U.S. 10-year Treasury yields. Short-term momentum has improved after a corrective phase that tested 50-day moving average support on several major indices. The analyst expects the rally to have upside into July, while no…

Brazil Vows Strong Response to Proposed 25% U.S. Tariff

Brazil Vows Strong Response to Proposed 25% U.S. Tariff

Brazil's Finance Minister Dario Durigan said the government will press its strongest legal and diplomatic arguments against a U.S. proposal to impose a 25% tariff on a broad range of Brazilian imports, and expressed hope the measure will not be enacted. Durigan described potential direct engagement between Presidents Lula and Trump and confirmed co…

CETY Partnership With Sagacity Yields Success in Design and Manufacture of Advanced ORC Components, Significantly Reducing System Costs and Strengthening Supply Chain Efficiency

CETY Partnership With Sagacity Yields Success in Design and Manufacture of Advanced ORC Components, Significantly Reducing System Costs and Strengthening Supply Chain Efficiency

Clean Energy Technologies, Inc. (CETY) announces successful progress in a manufacturing partnership with Sagacity, leading to reduced costs and improved supply chain efficiency for their Organic Rankine Cycle (ORC) waste heat recovery systems. This initiative supports scalable production and broader adoption of their clean energy technology across …

MAAS Subsidiary Huazhi Future Establishes Green Energy Infrastructure Research Team, Designates 800VDC as a Core Technology Focus

MAAS Subsidiary Huazhi Future Establishes Green Energy Infrastructure Research Team, Designates 800VDC as a Core Technology Focus

Maase Inc. announced that its subsidiary, Huazhi Future, has established a green energy infrastructure research team focused on 800-volt direct current (800VDC) technology. This initiative aims to develop scalable applications for 800VDC in intelligent computing centers, industrial parks, and renewable energy systems, enhancing transmission efficie…

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

XBiotech Inc. announced FDA clearance of its IND application for the V-SPINE study, a Phase II trial evaluating vilamakitug, a True Human™ anti-IL-1α antibody, in patients with active axial spondyloarthritis. The clearance allows US patient enrollment to commence, marking a key milestone in advancing XBiotech's rheumatology program targeting unmet …

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

Cosmos Health Inc. updates on its U.S. market entry with the 18 Series nutraceutical platform, introducing five products with four having disclosed projections totaling over $22.7 million in annualized revenue and $17 million in gross profit. The company highlights promising early momentum in direct-to-consumer sales and plans to expand distributio…

SailPoint Announces Intent to Acquire Entro to Accelerate and Enhance Agentic Fabric and Secure the Future of AI-Driven Enterprises

SailPoint Announces Intent to Acquire Entro to Accelerate and Enhance Agentic Fabric and Secure the Future of AI-Driven Enterprises

SailPoint, a US-based leader in enterprise identity security, announced its plan to acquire Tel Aviv-based Entro, a specialist in non-human identity and credentials security. This acquisition aims to enhance SailPoint's Agentic Fabric platform by integrating Entro's technologies, thereby advancing adaptive identity security for AI-driven enterprise…

Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product

Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product

Cuprina Holdings has received FDA 510(k) clearance for MEDIFLY Maggots, a patented Lucilia cuprina maggot debridement therapy product, marking the first U.S. clearance for this species. This approval enables Cuprina to market MEDIFLY Maggots for chronic wound treatment in the U.S. and supports global expansion plans. The clearance enhances Cuprina'…

LPL Financial Welcomes Fortress Financial Planning

LPL Financial Welcomes Fortress Financial Planning

LPL Financial announced that advisors from Fortress Financial Planning have joined its broker-dealer and Registered Investment Advisor platform, bringing approximately $150 million in assets. The move reinforces LPL's position as a leading wealth management firm supporting independent financial advisors with flexible and personalized service offeri…

Nuvei to Buy Payoneer for $2.75 Billion in Cash; Shares Rise in Premarket

Nuvei to Buy Payoneer for $2.75 Billion in Cash; Shares Rise in Premarket

Payoneer Global Inc. (NASDAQ:PAYO) agreed to be acquired by payments firm Nuvei in a $2.75 billion all-cash transaction valued at $7.40 per share. Payoneer shares climbed 3.4% in premarket trading as the boards of both companies approved the deal. The combined company is projected to generate roughly $3 billion in annual revenue and to process more…

Wearable Devices to Unveil GenAI-Powered Intent-Based Interface Platform and Next-Gen Mudra Pro Flagship at AWE 2026

Wearable Devices to Unveil GenAI-Powered Intent-Based Interface Platform and Next-Gen Mudra Pro Flagship at AWE 2026

Wearable Devices Ltd. announced its showcasing of a comprehensive neural input ecosystem at the Augmented World Expo 2026, highlighting its next-generation Mudra Pro hardware platform and Mudra Studio software platform leveraging generative AI. These innovations enable ultra-low latency, touchless, gesture-based controls for AI, augmented reality, …